Joshi SB - Search Results

1

Identifying stabilizers of plasmid DNA for pharmaceutical use.

Zeng Y, Ramsey JD, King R, Leviten M, Mcguire R, Volkin DB, Joshi SB, Middaugh CR. Zeng Y, et al. Among authors: joshi sb. J Pharm Sci. 2011 Mar;100(3):904-14. doi: 10.1002/jps.22330. Epub 2010 Aug 25. J Pharm Sci. 2011. PMID: 20740679

2

Anthrax vaccine powder formulations for nasal mucosal delivery.

Jiang G, Joshi SB, Peek LJ, Brandau DT, Huang J, Ferriter MS, Woodley WD, Ford BM, Mar KD, Mikszta JA, Hwang CR, Ulrich R, Harvey NG, Middaugh CR, Sullivan VJ. Jiang G, et al. Among authors: joshi sb. J Pharm Sci. 2006 Jan;95(1):80-96. doi: 10.1002/jps.20484. J Pharm Sci. 2006. PMID: 16315230

3

A systematic approach to stabilizing EBA-175 RII-NG for use as a malaria vaccine.

Peek LJ, Brandau DT, Jones LS, Joshi SB, Middaugh CR. Peek LJ, et al. Among authors: joshi sb. Vaccine. 2006 Jul 26;24(31-32):5839-51. doi: 10.1016/j.vaccine.2006.04.067. Epub 2006 May 12. Vaccine. 2006. PMID: 16735084

4

Probing protein structure and dynamics by second-derivative ultraviolet absorption analysis of cation-{pi} interactions.

Lucas LH, Ersoy BA, Kueltzo LA, Joshi SB, Brandau DT, Thyagarajapuram N, Peek LJ, Middaugh CR. Lucas LH, et al. Among authors: joshi sb. Protein Sci. 2006 Oct;15(10):2228-43. doi: 10.1110/ps.062133706. Epub 2006 Sep 8. Protein Sci. 2006. PMID: 16963649 Free PMC article.

5

Parathyroid hormone is a heparin/polyanion binding protein: binding energetics and structure modification.

Kamerzell TJ, Joshi SB, McClean D, Peplinskie L, Toney K, Papac D, Li M, Middaugh CR. Kamerzell TJ, et al. Among authors: joshi sb. Protein Sci. 2007 Jun;16(6):1193-203. doi: 10.1110/ps.062613807. Protein Sci. 2007. PMID: 17525467 Free PMC article.

6

Stability of the Clostridium botulinum type A neurotoxin complex: an empirical phase diagram based approach.

Brandau DT, Joshi SB, Smalter AM, Kim S, Steadman B, Middaugh CR. Brandau DT, et al. Among authors: joshi sb. Mol Pharm. 2007 Jul-Aug;4(4):571-82. doi: 10.1021/mp0601244. Epub 2007 Jun 7. Mol Pharm. 2007. PMID: 17552543

7

The interaction of heparin/polyanions with bovine, porcine, and human growth hormone.

Joshi SB, Kamerzell TJ, McNown C, Middaugh CR. Joshi SB, et al. J Pharm Sci. 2008 Apr;97(4):1368-85. doi: 10.1002/jps.21056. J Pharm Sci. 2008. PMID: 17705152

8

Preformulation studies of Clostridium difficile toxoids A and B.

Salnikova MS, Joshi SB, Rytting JH, Warny M, Middaugh CR. Salnikova MS, et al. Among authors: joshi sb. J Pharm Sci. 2008 Oct;97(10):4194-207. doi: 10.1002/jps.21300. J Pharm Sci. 2008. PMID: 18228584

9

Physical characterization of clostridium difficile toxins and toxoids: effect of the formaldehyde crosslinking on thermal stability.

Salnikova MS, Joshi SB, Rytting JH, Warny M, Middaugh CR. Salnikova MS, et al. Among authors: joshi sb. J Pharm Sci. 2008 Sep;97(9):3735-52. doi: 10.1002/jps.21261. J Pharm Sci. 2008. PMID: 18257030

10

Stabilization of measles virus for vaccine formulation.

Kissmann J, Ausar SF, Rudolph A, Braun C, Cape SP, Sievers RE, Federspiel MJ, Joshi SB, Middaugh CR. Kissmann J, et al. Among authors: joshi sb. Hum Vaccin. 2008 Sep-Oct;4(5):350-9. doi: 10.4161/hv.4.5.5863. Epub 2008 Sep 7. Hum Vaccin. 2008. PMID: 18382143

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters